Lymphoma 2027: A Comprehensive Clinical Update From Diagnosis to Cellular Therapy

Lymphoma 2027: A Comprehensive Clinical Update From Diagnosis to Cellular Therapy is organized by Columbia University Department of Medicine and will be held on Feb 26, 2027 at Columbia University Vagelos College of Physicians and Surgeons in New York, United States of America.

Description:
The conference is designed to provide participants with a comprehensive review of the most important advances in lymphoma-related disease and to help advance participants in the field.

Learning Objectives:

• Describe emerging molecular and genomic features of aggressive B-cell lymphomas and their implications for diagnosis, prognosis, and treatment selection.
• Apply current evidence-based strategies for the frontline and relapsed/refractory treatment of diffuse large B-cell lymphoma (DLBCL), including the appropriate use of novel agents.
• Evaluate contemporary treatment approaches for Hodgkin lymphoma, CLL, and indolent lymphomas, incorporating emerging therapies and patient-specific considerations.
• Recognize key diagnostic features and apply current therapeutic approaches for cutaneous and other T-cell lymphomas, including mycosis fungoides and Sézary syndrome.
• Assess the evolving role of cellular therapies, including CAR-T therapy and hematopoietic stem cell transplantation, in the management of patients with relapsed or refractory lymphoma.